Answers are grounded in this paper and cite their sources.
Background and Purpose: Magnetic resonance imaging (MRI) is often limited by safety concerns and long acquisition times in elderly patients. We evaluated the potential clinical utility of an artificial intelligence (AI) model, Morph Computed Tomography (CT) Plus, to predict three-year dementia conversion in mild cognitive impairment (MCI) using rapid low-dose CT scans, prioritizing its role as a safe and efficient triage tool. Methods: We analyzed 896 MCI (Clinical Dementia Rating [CDR]=0.5) patients from the Korea-Registries to Overcome Dementia and Accelerate Dementia Research cohort. A deep learning model quantified regional brain atrophy. We implemented a dual-cutoff risk-stratification strategy to optimize clinical workflow, comparing 90% and 95% sensitivity/specificity operating targets. Conclusions: AI-driven CT analysis provides a high-precision, inclusive triage tool. The 90% strategy offers a scalable solution for early dementia management, especially for patients with MRI contraindications, demonstrating significant potential clinical utility.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: